Analyst Reco. Teladoc Health, Inc.

Equities

TDOC

US87918A1051

Market Closed - Nyse Other stock markets 04:00:02 2024-04-24 pm EDT			5-day change	1st Jan Change
13.73 ^USD	-0.07%		+4.49%	-36.29%

Apr. 12	Teladoc Health, Inc. Announces Resignation of Richard J. Napolitano as Chief Accounting Officer, Effective May 3, 2024	CI
Apr. 08	Deutsche Bank Cuts Teladoc's Price Target to $18 From $22, Maintains Hold Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Deutsche Bank Cuts Teladoc's Price Target to $18 From $22, Maintains Hold Rating	Apr. 08	MT
Leerink Partners Initiates Coverage on Teladoc With Market Perform Rating, $17 Price Target	Feb. 26	MT
Deutsche Bank Adjusts Teladoc Price Target to $22 From $23, Maintains Hold Rating	Feb. 22	MT
Citigroup Adjusts Teladoc Price Target to $19 From $21, Maintains Neutral Rating	Feb. 21	MT
Barclays Trims Price Target on Teladoc to $25 From $26, Maintains Overweight Rating	Feb. 21	MT
Canaccord Genuity Lowers Price Target on Teladoc to $28 From $34, Maintains Buy Rating	Feb. 21	MT
Piper Sandler Adjusts Price Target on Teladoc to $25 From $30, Maintains Overweight Rating	Feb. 21	MT
RBC Cuts Price Target on Teladoc to $25 From $30, Notes 'Slower Expected Revenue Trajectory,' Keeps Outperform Rating	Feb. 21	MT
JPMorgan Adjusts Price Target on Teladoc to $19 From $33, Maintains Neutral Rating	Nov. 17	MT
UBS Adjusts Teladoc Price Target to $20 From $28, Maintains Neutral Rating	23-10-26	MT
Deutsche Bank Adjusts Teladoc Price Target to $23 From $29, Maintains Hold Rating	23-10-25	MT
Oppenheimer Adjusts Teladoc Price Target to $26 From $35, Maintains Outperform Rating	23-10-25	MT
RBC Cuts Price Target on Teladoc to $30 From $35, Keeps Outperform Rating	23-10-25	MT
Citigroup Cuts Price Target on Teladoc to $21 From $29, Keeps Neutral Rating	23-10-20	MT
Evercore ISI Raises Teladoc's Price Target to $25 From $23, In Line Rating Kept	23-07-26	MT
Citigroup Cuts Teladoc's Price Target to $29 From $31, Neutral Rating Kept	23-07-26	MT
UBS Adjusts Teladoc Price Target to $28 From $30, Maintains Neutral Rating	23-07-26	MT
Deutsche Bank Adjusts Teladoc Price Target to $29 From $27, Maintains Hold Rating	23-04-28	MT
UBS Raises Teladoc Price Target to $30 From $29, Maintains Neutral Rating	23-04-27	MT
Barclays Adjusts Price Target on Teladoc to $29 From $28, Keeps Equalweight Rating	23-04-27	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Teladoc Health, Inc.

Equities

TDOC

US87918A1051

Analyst Reco.

Filters